Browsing by Author Pang, WC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 11 of 11
TitleAuthor(s)Issue DateViews
 
2001
159
 
Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes
Proceeding/Conference:The 4th Congress of Asian Pacific Society of Atherosclerosis and Vascular Diseases. Bali, May 2004
2004
175
 
Effects of Sandostatin(R) LAR(R) on lipoprotein metabolism in patients with acromegaly - a six-month prospective study
Proceeding/Conference:83rd Annual Meeting of the Endocrine Society, Denver, USA
2001
120
 
Inhibition of hepatocellular carcinoma tumourigenicity by RNAi-mediated PIN1 silencing (Abstract)
Proceeding/Conference:The 6th Annual Scientific Meeting, Centre for the Study of Liver Disease, The University of Hong Kong, Hong Kong, 8 January 2005
2005
184
 
Plasma apolipoprotein(a) levels and phenotypes in NIDDM patients with various stages of diabetic nephropathy
Proceeding/Conference:Astract of 3rd International Diabetes Federation Western Pacific Regional Congress, Hong Kong, September 1996
1996
120
 
2005
151
 
RNAi-mediated PIN1 silencing inhibits HCC tumourigenicity (Abstract)
Proceeding/Conference:The 4th International Meeting on Hepatocellular Carcinoma: Eastern and Western Experiences, Hong Kong, 14-16 December 2004
2004
143
 
RNAi-mediated silencing of PIN1 inhibits HCC tumorigenicity
Proceeding/Conference:The 11th Hong Kong International Cancer Congress, Hong Kong, 10-12 November, 2004
2004
147
 
1996
150
 
Treatment of a acromegaly with Sandostatin (R) LAR associated with increase in lipoprotein lipase activity and HDL levels.
Proceeding/Conference:11th International Congress of Endocrinology, Sydney, Australia
2000
149
 
Treatment of hyperlipidaemia in patients with non-insulin-dependent diabetes mellitus with progressive nephropathy
Book:In: Keane W.F., Horl W.H. and Kasiske B.L. (eds.), Lipids and the Kidney
1998
267